T

The Leukemia & Lymphoma Society

2303 employees

Leukemia & Lymphoma Society, a voluntary health organization, funds research, finds cures, and offers treatments for blood cancer patients.

Investor insights

Sectors invested in

Biotechnology11
Health Care8
Medical5
Biopharma5
Therapeutics5
Pharmaceutical4
Pharmaceuticals2
Drug discovery2
Novel treatments for medical conditions with significant unmet needs2
Drug development2
biopharmaceutical2
Cancer immunotherapy2
Acute Respiratory Distress Syndrome2
ARDS2
Life Science2
oncology2
Next-generation CRISPR genome editing1
Genetics1
Biologics1
Cancer1

Funding rounds participated in

$13M sweet spot round size

Most of their 11 investments are in rounds between $6M and $73M

Investor type

Venture Capital

Basic info

Industry

non-profit organization management

Sectors

Team In Training
Man & Woman of the Year
LTN
MWOY
LLS
patient support
Light The Night® Walk
BLOOD CANCER
Student Series
Fighting blood cancer
cancer
TNT
blood cancer
The Leukemia Cup Regatta®

Date founded

1949

Investments made

F

Faron raised $13M on January 27, 2023

Investors: The Leukemia & Lymphoma Society

F

Faron raised $5.3M on June 28, 2022

Investors: The Leukemia & Lymphoma Society

I

Imcheck Therapeutics raised $100M on June 13, 2022

Investors: Pureos Bioventures, Gimv, The Invus Group, Earlybird Venture Capital, Eurazeo, Wellington Partners, EQT Life Sciences and The Leukemia & Lymphoma Society

I

Immunitas Therapeutics raised $58M on August 18, 2021

Investors: NS Investment, M Ventures, Solasta Ventures, Mirae Asset MAPS Global Investments Co., Ltd, Longwood Fund, Medical Excellence Capital, LLC and The Leukemia & Lymphoma Society

I

Immune-Onc Therapeutics raised $73M on March 30, 2021

Investors: Octagon Capital Advisors, Northern Light Venture Capital, Vivo Capital, Oceanpine Capital and The Leukemia & Lymphoma Society

C

Caribou Biosciences raised $115M on March 3, 2021

Investors: Maverick Ventures, Partner Fund Management, Monashee Investment Management LLC, Tekla Capital Management, Point72 Ventures, LifeSci Venture Partners, Ridgeback Capital Management LLC, Mission BioCapital and The Leukemia & Lymphoma Society

K

Kymera Therapeutics raised undisclosed on March 12, 2020

Investors: The Leukemia & Lymphoma Society

F

Forty Seven Inc. raised $6M on August 7, 2019

Investors: The Leukemia & Lymphoma Society

O

OncoPep, Inc. raised $6.9M on August 28, 2014

Investors: The Leukemia & Lymphoma Society

C

Constellation Pharmaceuticals raised undisclosed on September 1, 2012

Investors: The Leukemia & Lymphoma Society

FAQ